SA国际传媒

Sunday 27 September 2026
Salisbury Foundation Trust

FOI_9577

Internal Reference Number: FOI_9577

Date Request Received: 27/07/2026 00:00:00

Date Request Replied To: 12/08/2026 00:00:00

This response was sent via: By Email

Request Summary: Rare Disease Patients and Treatment

Request Category: Companies

 
Question Number 1:
FOI Request: Rare Disease Patients and Treatment

How many total patients has the trust seen within the latest 24 months of available data (for any reason), with a recorded diagnosis of Dravet Syndrome (DS)
 
Answer To Question 1:
Please note, we are unable to provide separate answers to Q1 and Q4 as the same ICD-10 diagnosis code is used to code both diagnoses: G40.4 Other generalised epilepsy and epileptic syndromes (includes Dravet syndrome and Lennox-Gastaut syndrome)

Answer <=5
 
Question Number 2:
Of total DS patients, how many have been treated with Epidyolex (Cannabidiol) in the last 12 months?
 
Answer To Question 2:
0
 
Question Number 3:
Of total DS patients, how many have been treated with Fintepla (Fenfluramine) in the last 12 months?
 
Answer To Question 3:
0
 
Question Number 4:
How many total patients has the trust seen within the latest 24 months of available data (for any reason), with a recorded diagnosis of Lennox-Gasteau Syndrome (LGS)
 
Answer To Question 4:
Please note, we are unable to provide separate answers to Q1 and Q4 as the same ICD-10 diagnosis code is used to code both diagnoses: G40.4 Other generalised epilepsy and epileptic syndromes (includes Dravet syndrome and Lennox-Gastaut syndrome)

Answer <=5
 
Question Number 5:
Of total LGS patients, how many have been treated with Epidyolex (Cannabidiol) in the last 12 months?
 
Answer To Question 5:
0
 
Question Number 6:
Of total LGS patients, how many have been treated with Fintepla (Fenfluramine) in the last 12 months?
 
Answer To Question 6:
0
 
Question Number 7:
How many adult (aged 18+) patients has the trust seen within the latest 24 months of available data (for any reason), with a recorded diagnosis of Dravet Syndrome (DS)
 
Answer To Question 7:
Please note, we are unable to provide separate answers to Q7 and Q8 as the same ICD-10 diagnosis code is used to code both diagnoses: G40.4 Other generalised epilepsy and epileptic syndromes (includes Dravet syndrome and Lennox-Gastaut syndrome)

Answer <=5
 
Question Number 8:
How many adult (aged 18+) patients has the trust seen within the latest 24 months of available data (for any reason), with a recorded diagnosis of Lennox-Gasteau Syndrome (LGS)
 
Answer To Question 8:
Please note, we are unable to provide separate answers to Q1 and Q4 as the same ICD-10 diagnosis code is used to code both diagnoses: G40.4 Other generalised epilepsy and epileptic syndromes (includes Dravet syndrome and Lennox-Gastaut syndrome)

Answer <=5
 
To return to the list of all the FOI requests please click here

Our staff at SA国际传媒 Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

SA国际传媒, SA国际传媒 Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2026 SA国际传媒
Trust Values
</